| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260572.1 |
AKT inhibitor VIII |
Colon adenocarcinoma |
0.024862774 |
Resistant |
| ENSG00000260572.1 |
AKT inhibitor VIII |
Brain lower grade glioma |
0.032502712 |
Resistant |
| ENSG00000260572.1 |
AKT inhibitor VIII |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014610157 |
Sensitive |
| ENSG00000260572.1 |
AKT inhibitor VIII |
Liver hepatocellular carcinoma |
0.028232347 |
Sensitive |
